Literature DB >> 32876245

Estimates of the impact of COVID-19 on mortality of institutionalized elderly in Brazil.

Carla Jorge Machado1, Claudia Cristina de Aguiar Pereira2, Bernardo de Mattos Viana3, Graziella Lage Oliveira1, Daniel Carvalho Melo4, Jáder Freitas Maciel Garcia de Carvalho5, Flávia Lanna de Moraes6, Edgar Nunes de Moraes7.   

Abstract

The COVID-19 pandemic poses difficulties for long-term care institutions for the elderly, with increased mortality rates for the residents. This study aims to estimate the impact of COVID-19 on mortality of institutionalized elderly in Brazil. Estimates of the percentage of elderly deaths occurring in care homes were calculated for Brazil, States and Regions using estimates for the total number of deaths. The estimation was based upon information available for other countries. The weighted percentage was 44.7% and 107,538 COVID-19 deaths were estimated for the elderly in these institutions in Brazil in 2020. Higher numbers of deaths were expected in the Southeast Region (48,779 deaths), followed by the Northeast Region (28,451 deaths); São Paulo was the most affected State (24,500 deaths). The strong impact of COVID-19 on the elderly population living in long-term care facilities is clear. Estimates for the country exceeded 100,000 elderly people, potentially the most fragile and vulnerable, and are based upon a conservative number of total deaths, in view of other estimates and the alarming situation of death growth in Brazil from COVID-19.

Entities:  

Mesh:

Year:  2020        PMID: 32876245     DOI: 10.1590/1413-81232020259.14552020

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  3 in total

1.  Out-of-Season Influenza during a COVID-19 Void in the State of Rio de Janeiro, Brazil: Temperature Matters.

Authors:  Rohini Nott; Trevon L Fuller; Patrícia Brasil; Karin Nielsen-Saines
Journal:  Vaccines (Basel)       Date:  2022-05-23

2.  Risk factors associated with mortality in patients hospitalized for coronavirus disease 2019 in Rio de Janeiro, Brazil.

Authors:  Julio César Delgado Correal; Victor Edgar Fiestas Solórzano; Paula Hesselberg Damasco; Maria de Lourdes Martins; Adriana Guerreiro Soares de Oliveira; Carla Salles Campos; Marcos Fernando Fornasari; Elzinandes Leal de Azeredo; Paulo Vieira Damasco
Journal:  Rev Soc Bras Med Trop       Date:  2021-03-22       Impact factor: 1.581

3.  COVID-19 Trials: Who Participates and Who Benefits?

Authors:  Shanti Narayanasamy; Ahmad Mourad; Nicholas A Turner; Thuy Le; Robert J Rolfe; Nwora Lance Okeke; Sean M O'Brien; Arthur W Baker; Rebekah Wrenn; Rossana Rosa; Frank W Rockhold; Susanna Naggie; Jason E Stout
Journal:  South Med J       Date:  2022-04       Impact factor: 0.954

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.